搜索临床试验以:胰岛移植
总计2616个结果
-
The Second Hospital of Nanjing Medical University撤销COVID-19 Complicated With Refractory Intestinal Infections中国
-
Kessler FoundationUniversity of Southern California; VA Office of Research and Development; Kessler Institute for... 和其他合作者未知
-
The Second Hospital of Nanjing Medical UniversitySIR RUN RUN hospital of Nanjing Medical University尚未招聘
-
Children's Mercy Hospital Kansas CityUniversity of Pittsburgh; Stanford University完全的
-
Royan InstituteSmall Business Developing Center; Labafi Nejad Eye Research Center完全的
-
The Second Hospital of Nanjing Medical UniversitySIR RUN RUN hospital of Nanjing Medical University招聘中
-
Wake Forest University Health Sciences完全的
-
Chinese Academy of SciencesThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School未知
-
OHSU Knight Cancer InstituteOregon Health and Science University可用的
-
International Peace Maternity and Child Health...Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China完全的
-
Southern Medical University, ChinaCellonis Biotechnology Co. Ltd.; The Second People's Hospital of Nanhai District of Foshan; The...完全的
-
Chinese Academy of SciencesThe Third Affiliated Hospital of Guangzhou Medical University未知
-
Medical University of GrazBristol-Myers Squibb终止
-
Groupe Francophone des MyelodysplasiesNovartis; Neovii Biotech主动,不招人
-
Roswell Park Cancer InstituteCelgene撤销复发性急性髓性白血病 | 难治性急性髓性白血病 | IDH2基因突变 | 原始细胞低于 5% 的外周血白细胞 | 与治疗前水平相比,骨髓原始细胞减少了 50% 或更多美国
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Marrow... 和其他合作者完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)终止急性淋巴细胞白血病 | 套细胞淋巴瘤 | 非霍奇金淋巴瘤 | 骨髓增生异常综合症 | 浆细胞骨髓瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 最小残留病 | 治疗相关的急性髓性白血病 | 治疗相关性骨髓增生异常综合征 | 造血细胞移植受者 | 复发性血液系统恶性肿瘤 | TP53基因突变 | 难治性成熟 T 细胞和 NK 细胞非霍奇金淋巴瘤 | 复发性成熟 T 细胞和 NK 细胞非霍奇金淋巴瘤 | 缓解期急性髓性白血病 | JAK2基因突变 | 染色体 17p 丢失 | RAS家族基因突变美国